For patients managing oncology care, this generic medicine inhibits the conversion of androgens to estrogens, reducing hormonal support for specific cell growth.
Information related to Aromasin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.